$-0.32 EPS Expected for Verastem (VSTM); Alliqua Biomedical DE (ALQA) Shorts Raised By 27.71%

October 13, 2017 - By marketbeat

Analysts expect Verastem Inc (NASDAQ:VSTM) to report $-0.32 EPS on November, 6.They anticipate $0.11 EPS change or 52.38% from last quarter’s $-0.21 EPS. After having $-0.36 EPS previously, Verastem Inc’s analysts see -11.11% EPS growth. About 624,172 shares traded. Verastem Inc (NASDAQ:VSTM) has risen 71.53% since October 13, 2016 and is uptrending. It has outperformed by 54.83% the S&P500.

Alliqua Biomedical DE (NASDAQ:ALQA) had an increase of 27.71% in short interest. ALQA’s SI was 1.03M shares in October as released by FINRA. Its up 27.71% from 804,900 shares previously. With 1.65 million avg volume, 1 days are for Alliqua Biomedical DE (NASDAQ:ALQA)’s short sellers to cover ALQA’s short positions. The SI to Alliqua Biomedical DE’s float is 3.76%. About 32,276 shares traded. Alliqua Biomedical Inc (NASDAQ:ALQA) has declined 66.38% since October 13, 2016 and is downtrending. It has underperformed by 83.08% the S&P500.

Alliqua BioMedical, Inc. is a provider of advanced wound care solutions. The company has market cap of $15.08 million. The Company’s businesses include advanced wound care and contract manufacturing. It currently has negative earnings. The Firm operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc.

Investors sentiment increased to 1.71 in Q2 2017. Its up 0.33, from 1.38 in 2017Q1. It is positive, as 0 investors sold Alliqua Biomedical Inc shares while 7 reduced holdings. 6 funds opened positions while 6 raised stakes. 10.86 million shares or 9.62% less from 12.02 million shares in 2017Q1 were reported. Perceptive Limited Liability Corp stated it has 0.08% of its portfolio in Alliqua Biomedical Inc (NASDAQ:ALQA). Pura Vida Invests Ltd Com has 1.21 million shares. Jnba Financial Advsrs holds 0% or 3 shares. Sabby Management Limited Liability Corporation has invested 0.03% in Alliqua Biomedical Inc (NASDAQ:ALQA). Renaissance Technologies Ltd Limited Liability Company reported 848,500 shares. Wells Fargo & Company Mn has 0% invested in Alliqua Biomedical Inc (NASDAQ:ALQA) for 428 shares. Bank & Trust Of America De owns 3,097 shares for 0% of their portfolio. Vanguard Group Incorporated reported 0% in Alliqua Biomedical Inc (NASDAQ:ALQA). The Illinois-based Citadel Advisors Ltd has invested 0% in Alliqua Biomedical Inc (NASDAQ:ALQA). Morgan Stanley stated it has 6,776 shares or 0% of all its holdings. Bank Of Montreal Can stated it has 3,500 shares or 0% of all its holdings. Da Davidson & Co invested 0% in Alliqua Biomedical Inc (NASDAQ:ALQA). Tekla Mngmt Ltd Co holds 0.02% or 1.65M shares in its portfolio. Janney Montgomery Scott Ltd holds 0% or 87,500 shares. Geode Capital Mngmt Ltd Liability invested in 0% or 76,706 shares.

Among 3 analysts covering Alliqua Biomedical (NASDAQ:ALQA), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Alliqua Biomedical had 10 analyst reports since August 19, 2015 according to SRatingsIntel. H.C. Wainwright maintained the stock with “Buy” rating in Friday, April 7 report. Chardan Capital Markets maintained the shares of ALQA in report on Friday, November 6 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, November 6. The firm has “Buy” rating given on Monday, November 2 by H.C. Wainwright. The stock of Alliqua Biomedical Inc (NASDAQ:ALQA) earned “Buy” rating by Chardan Capital Markets on Wednesday, February 24. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, August 10. RBC Capital Markets maintained Alliqua Biomedical Inc (NASDAQ:ALQA) on Wednesday, February 24 with “Outperform” rating. On Wednesday, August 19 the stock rating was downgraded by Zacks to “Hold”.

Among 10 analysts covering Verastem (NASDAQ:VSTM), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Verastem had 26 analyst reports since September 9, 2015 according to SRatingsIntel. The stock of Verastem Inc (NASDAQ:VSTM) has “Hold” rating given on Tuesday, August 9 by Jefferies. The rating was downgraded by Jefferies to “Hold” on Tuesday, September 29. Oppenheimer maintained Verastem Inc (NASDAQ:VSTM) on Tuesday, August 8 with “Buy” rating. The rating was downgraded by TH Capital to “Neutral” on Monday, September 28. Raymond James initiated Verastem Inc (NASDAQ:VSTM) on Wednesday, September 9 with “Strong Buy” rating. The firm earned “Neutral” rating on Monday, September 28 by Mizuho. The stock of Verastem Inc (NASDAQ:VSTM) earned “Overweight” rating by Cantor Fitzgerald on Wednesday, September 6. Raymond James downgraded the stock to “Outperform” rating in Tuesday, September 29 report. Roth Capital downgraded the stock to “Neutral” rating in Monday, September 28 report. On Monday, June 26 the stock rating was maintained by Oppenheimer with “Buy”.

Since May 15, 2017, it had 1 buy, and 0 sales for $73,500 activity. BARBERICH TIMOTHY J had bought 30,000 shares worth $73,500 on Monday, May 15.

Verastem, Inc. is a biopharmaceutical company. The company has market cap of $161.66 million. The Firm is focused on discovering and developing drugs to improve outcomes for patients with cancer. It currently has negative earnings. The Firm operates in the segment of developing drugs for the treatment of cancer.

Investors sentiment increased to 1.17 in 2017 Q2. Its up 0.07, from 1.1 in 2017Q1. It is positive, as 5 investors sold Verastem Inc shares while 18 reduced holdings. 13 funds opened positions while 14 raised stakes. 8.68 million shares or 12.61% more from 7.71 million shares in 2017Q1 were reported. Wells Fargo And Mn has 0% invested in Verastem Inc (NASDAQ:VSTM) for 20,950 shares. Panagora Asset Mngmt owns 28,168 shares for 0% of their portfolio. Blackrock has invested 0% of its portfolio in Verastem Inc (NASDAQ:VSTM). Tfs Llc invested in 29,495 shares or 0.03% of the stock. Hightower Advsr Ltd Company reported 0% of its portfolio in Verastem Inc (NASDAQ:VSTM). Art Advsrs Ltd Llc has invested 0.01% in Verastem Inc (NASDAQ:VSTM). Guggenheim Lc has 12,805 shares for 0% of their portfolio. Oppenheimer reported 10,219 shares. Grt Cap Prtn Limited Liability holds 0.03% or 22,405 shares in its portfolio. Awm Inv Incorporated accumulated 50,000 shares. Jpmorgan Chase Co holds 251 shares. Deutsche Fincl Bank Ag holds 361,043 shares. Prelude Cap Limited Liability Corp reported 0% in Verastem Inc (NASDAQ:VSTM). Two Sigma Securities Limited Com stated it has 10,554 shares or 0% of all its holdings. Bridgeway Cap Mgmt Inc reported 0.01% stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com